Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan versus valsartan in acute STEMI
IRCT20251213068301N1Phase 4Recruiting
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in myocardial infarction (MI) comparing Telmisartan with Valsartan (2 arms). Primary endpoints: Change in total cholesterol, Change in LDL cholesterol and 5 more. Started Jan 2026; status: recruiting.
02
Drugs
telmisartanvalsartan
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20251213068301N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251213068301N1.